On Drugs

On Drugs Your article1 implied that there are scientific reasons why research-ers don't support drug decriminalization. But there's a much better explanation: They want to keep their jobs and their grants. NIDA [National Institute on Drug Abuse] assistant director Hanson wouldn't even support needle exchange--for which the evidence is overwhelming--when the chips were down. Director Volkow claims, despite the evidence, that we don't know yet whether marijuana is toxic to the adolescent brai

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Your article1 implied that there are scientific reasons why research-ers don't support drug decriminalization. But there's a much better explanation: They want to keep their jobs and their grants.

NIDA [National Institute on Drug Abuse] assistant director Hanson wouldn't even support needle exchange--for which the evidence is overwhelming--when the chips were down. Director Volkow claims, despite the evidence, that we don't know yet whether marijuana is toxic to the adolescent brain.

But, we've run a natural experiment on that question for the last 30 years, with teen-use rates ranging from 50% to 70% around the developed world. If marijuana were really harmful, we should have seen some evidence by now. Despite an exhaustive search (and remember that studies showing no effect are far less likely to get published), there's no evidence for significant, permanent impairment even in the heaviest users. There's no evidence to support the notion that pot leads ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Maia Szalavitz

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution